BIOMAT Database Logo BIOMAT Database Logo

Cyclophosphamide in chronic active hepatitis. 1979

R Althouse, and J E Huff, and L Tomatis, and J D Wilbourn

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Althouse, and J E Huff, and L Tomatis, and J D Wilbourn
Treatment of active chronic hepatitis with cyclophosphamide.
January 1974, Postgraduate medical journal,
R Althouse, and J E Huff, and L Tomatis, and J D Wilbourn
Controlled trial of cyclophosphamide in active chronic hepatitis.
April 1979, British medical journal,
R Althouse, and J E Huff, and L Tomatis, and J D Wilbourn
[Association of autoimmune chronic active hepatitis and acquired erythroblastopenia cured by cyclophosphamide].
December 1986, Gastroenterologie clinique et biologique,
R Althouse, and J E Huff, and L Tomatis, and J D Wilbourn
[Active chronic hepatitis].
November 1971, Revista espanola de las enfermedades del aparato digestivo,
R Althouse, and J E Huff, and L Tomatis, and J D Wilbourn
Chronic active hepatitis.
July 1980, British medical journal,
R Althouse, and J E Huff, and L Tomatis, and J D Wilbourn
[Active chronic hepatitis].
January 1972, Medicina,
R Althouse, and J E Huff, and L Tomatis, and J D Wilbourn
[Active chronic hepatitis].
April 1972, Soins; la revue de reference infirmiere,
R Althouse, and J E Huff, and L Tomatis, and J D Wilbourn
Chronic active hepatitis.
September 1976, The Indian journal of medical research,
R Althouse, and J E Huff, and L Tomatis, and J D Wilbourn
Chronic active hepatitis.
June 1984, American family physician,
R Althouse, and J E Huff, and L Tomatis, and J D Wilbourn
Active chronic hepatitis.
November 1976, The Central African journal of medicine,
Copied contents to your clipboard!